Background Several randomized controlled trials (RCT s) have already shown that
paclitaxel‐coated balloons and stents significantly reduce the rates of vessel restenosis and …

The recommendations listed in this guideline are, whenever possible, evidence based. An
initial extensive evidence review, which included literature derived from research involving …

W 2011 roku ESC opublikowało pierwsze wytyczne dotyczące rozpoznawania i leczenia
chorób tętnic obwodowych (PAD)[1]. Ta publikacja wypełniła ważną lukę wśród wytycznych …

Document Reviewers b, Petr Widimsky, Philippe Kolh, Stefan Agewall, Héctor Bueno,
Antonio Coca, Gert J. De Borst, Victoria Delgado, Florian Dick, Cetin Erol, Marc Ferrini …

Aims Drug-eluting devices (DED) represent a well-established therapy being widely used for
endovascular revascularization (EVR) of peripheral vessels. Recent data indicate a two-fold …

Advances in endovascular therapies during the past decade have broadened the options for
treating peripheral vascular disease percutaneously. Endovascular treatment offers a lower …

Critical limb ischemia (CLI) is a clinical syndrome of ischemic pain at rest or tissue loss, such
as nonhealing ulcers or gangrene, related to peripheral artery disease. CLI has a high short …

In 2014, the Society for Cardiovascular Angiography and Interventions (SCAI) published the
first Appropriate Use Criteria (AUC) for endovascular therapy (EVT) for atherosclerotic …

Endovascular stenting has matured into a commonly used treatment for peripheral arterial
disease (PAD) due to its minimally invasive nature and associated reductions in short-term …

Objectives: The hypothesis that paclitaxel-eluting balloon angioplasty provides higher 1-
year patency rates in femoropopliteal artery in-stent restenosis compared with standard …